SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-260008
Filing Date
2023-10-20
Accepted
2023-10-20 17:15:53
Documents
5
Effectiveness Date
2023-10-20

Document Format Files

Seq Description Document Type Size
1 S-8 d878481ds8.htm S-8 64730
2 EX-5.1 d878481dex51.htm EX-5.1 8557
3 EX-23.1 d878481dex231.htm EX-23.1 1457
4 EX-FILING FEES d878481dexfilingfees.htm EX-FILING FEES 40939
5 GRAPHIC g878481g1018101944179.jpg GRAPHIC 2196
  Complete submission text file 0001193125-23-260008.txt   120076
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-275124 | Film No.: 231337757
SIC: 3826 Laboratory Analytical Instruments
Industrial Applications and Services